In a recent development, the Australian Technical Advisory Group on Immunisation (ATAGI) has issued new recommendations calling for additional COVID-19 vaccine booster for specific high-risk groups in 2023. These recommendations build upon the initial booster ...
As Australia heads towards the fourth winter of the pandemic, we have once again started seeing an increase in the level of COVID circulating. With this comes an increased risk of infection and serious illness. ...
In a world first, James Cook University researchers have developed a new way to rate the effectiveness of Rapid Antigen Tests (RATs), which could lead to more reliable testing of patients. The research highlights the ...
The world’s largest study of multiple interventions for critically ill COVID-19 patients on longer-term outcomes shows results from a 6-month follow-up. The world’s largest trial into the effect of multiple interventions for critically ill adults ...
The Australian Government has launched the National COVID-19 Health Management Plan for 2023 to ensure Australia’s healthcare system has the capacity and capability to respond to future waves and variants of the virus. Although the ...
According to a new report by the Australian Institute of Health and Welfare, Australia’s spending on health goods and services during the COVID-19 pandemic grew to $220.9 billion. Spending on health goods and services grew ...
Professor Jane Halton AO has handed to Government her independent review of Australia’s COVID-19 vaccine and treatment procurements, making eight recommendations. The recommendations cover the need for public health campaigns around vaccine uptake, an updated ...
The Australian Government has accepted a recommendation from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of the Moderna Spikevax Bivalent Original/Omicron BA.1 vaccine as a third and fourth dose in people ...
A new report reveals some of the effects of the COVID-19 pandemic on general practice in Australia. The data used is poised to shine a light on how COVID-19 affects long-term health. NPS MedicineWise released ...
The Australian Government is providing $31.5 million for COVID-19 research to support medical researchers to drive, and contribute to, global efforts to understand and treat COVID. The Albanese Government will boost support for COVID-19 research ...
Novavax COVID-19 vaccine (Nuvaxovid) has been provisionally approved by the Australian Therapeutic Goods Agency (TGA) for use in adolescents aged 12 to 17 years. The Australian Technical Advisory Group on Immunisation (ATAGI) has evaluated data ...
The Department of Health and Aged Care is extending its Expression of Interest (EOI) process for COVID-19 in-reach vaccination clinics until 31 December 2022, allowing any residents who were unable to receive their COVID-19 vaccinations ...
Healthcare Channel – Sharing knowledge and resources for Australia’s health and aged care sector
We always welcome thought leaders ready to mentor the next generation. Be a Healthcare Channel learning partner today!
Healthcare Channel acknowledges the traditional custodians of the lands where we live, learn and work. We pay our respects to Elders past, present and emerging.
Healthcare Channel acknowledges the traditional custodians of the lands where we live, learn and work. We pay our respects to Elders past, present and emerging.
